These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 31094130

  • 21. [Plasma cell leukemia].
    Ravinet A, Bay JO, Tournilhac O.
    Bull Cancer; 2014 Nov; 101(11):1048-58. PubMed ID: 25418598
    [Abstract] [Full Text] [Related]

  • 22. Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment.
    Brück P, Mousset S, Bühme A, Hoelzer D, Atta J.
    Int J Hematol; 2007 Jul; 86(1):66-8. PubMed ID: 17675269
    [Abstract] [Full Text] [Related]

  • 23. Primary plasma cell leukaemia in a 39-year-old man.
    Kasinathan G.
    BMJ Case Rep; 2020 Jul 23; 13(7):. PubMed ID: 32709663
    [Abstract] [Full Text] [Related]

  • 24. Plasma cell leukemia.
    Hayman SR, Fonseca R.
    Curr Treat Options Oncol; 2001 Jun 23; 2(3):205-16. PubMed ID: 12057120
    [Abstract] [Full Text] [Related]

  • 25. [IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review].
    Adam Z, Feit J, Krejcí M, Pour L, Vasků V, Cermáková Z, Mayer J, Hájek R.
    Vnitr Lek; 2009 Oct 23; 55(10):981-90. PubMed ID: 19947244
    [Abstract] [Full Text] [Related]

  • 26. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
    Iino M, Nakajima A, Shindo H.
    Gan To Kagaku Ryoho; 2008 Dec 23; 35(13):2441-3. PubMed ID: 19098420
    [Abstract] [Full Text] [Related]

  • 27. Plasma cells with hairy projections and Auer rod-like inclusions in a patient with multiple myeloma.
    Sharma P, Sachdeva MUS, Ahluwalia J, Malhotra P.
    BMJ Case Rep; 2017 Aug 03; 2017():. PubMed ID: 28775092
    [No Abstract] [Full Text] [Related]

  • 28. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
    Kim HJ, Yoon SS, Lee DS, Sohn SK, Eom HS, Lee JL, Chung JS, Kim K, Suh C, Won JH, Kim JS, Park JS, Kang HJ, Seong CM, Kim CS, Lee SJ, Lee JH.
    Ann Hematol; 2012 Feb 03; 91(2):249-56. PubMed ID: 21789621
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
    Musto P, Rossini F, Gay F, Pitini V, Guglielmelli T, D'Arena G, Ferrara F, Filardi N, Guariglia R, Palumbo A, GISMM Cooperative Group, GISL Cooperative Group, GIMEMA Cooperative Group.
    Cancer; 2007 Jun 01; 109(11):2285-90. PubMed ID: 17469169
    [Abstract] [Full Text] [Related]

  • 30. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
    Katodritou E, Terpos E, Kelaidi C, Kotsopoulou M, Delimpasi S, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Stefanoudaki A, Christoulas D, Chatziaggelidou C, Gastari V, Spyridis N, Verrou E, Konstantinidou P, Zervas K, Dimopoulos MA.
    Am J Hematol; 2014 Feb 01; 89(2):145-50. PubMed ID: 24123068
    [Abstract] [Full Text] [Related]

  • 31. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling.
    Nonami A, Miyamoto T, Kuroiwa M, Kunisaki Y, Kamezaki K, Takenaka K, Harada N, Teshima T, Harada M, Nagafuji K.
    Jpn J Clin Oncol; 2007 Dec 01; 37(12):969-72. PubMed ID: 18055567
    [Abstract] [Full Text] [Related]

  • 32. Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood stem cell transplantation and interferon-alpha.
    Panizo C, Rifón J, Rodríguez-Wilhelmi P, Cuesta B, Rocha E.
    Acta Haematol; 1999 Dec 01; 101(4):193-6. PubMed ID: 10436300
    [Abstract] [Full Text] [Related]

  • 33. [Salvage therapy with proteasome inhibitor bortezomib for relapsed and refractory multiple myeloma].
    Huang WR, Li R, Jing Y, Zhang YZ, Wu XX, Gao CJ, Bo J, Yu L, Wang QS, Da WM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec 01; 14(6):1146-50. PubMed ID: 17204182
    [Abstract] [Full Text] [Related]

  • 34. [Plasma cell leukemia. Study of 10 cases].
    López Guillermo A, Martí JM, Bladé J, Nomdedeu B, Montserrat E, Rozman C.
    Sangre (Barc); 1989 Feb 01; 34(1):28-31. PubMed ID: 2652343
    [Abstract] [Full Text] [Related]

  • 35. Plasma cell leukemia: case report of a rare and aggressive variant of multiple myeloma.
    Jameel A.
    J Pak Med Assoc; 2005 Oct 01; 55(10):452-3. PubMed ID: 16304856
    [Abstract] [Full Text] [Related]

  • 36. Plasma cell leukaemia.
    Braga CG, Rodrigues AR, Alves M, Portela C, Pinto L, Marques H.
    Porto Biomed J; 2016 Oct 01; 1(2):49-51. PubMed ID: 32258549
    [Abstract] [Full Text] [Related]

  • 37. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y, Shimada A, Wakabayashi M, Sugimoto K, Tomita S, Izumi H, Nakamura N, Sawada T, Ohta Y, Komatsu N, Noguchi M.
    Int J Clin Exp Pathol; 2014 Oct 01; 7(9):6313-22. PubMed ID: 25337285
    [Abstract] [Full Text] [Related]

  • 38. A Rare Case of Primary Plasma Cell Leukaemia with Monosomy X.
    Masamatti SS, Narasimha A, Shetty AC, Vijaya C.
    J Clin Diagn Res; 2017 Aug 01; 11(8):ED06-ED07. PubMed ID: 28969143
    [Abstract] [Full Text] [Related]

  • 39. Plasma cell leukemia: update on biology and therapy.
    Mina R, D'Agostino M, Cerrato C, Gay F, Palumbo A.
    Leuk Lymphoma; 2017 Jul 01; 58(7):1538-1547. PubMed ID: 27819179
    [Abstract] [Full Text] [Related]

  • 40. Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.
    Cook G, Marinaki P, Farrell E, Pearson C, Alcorn MJ, Sharp RA, Tansey PJ, Franklin IM.
    Leukemia; 1997 Dec 01; 11 Suppl 5():S35-40. PubMed ID: 9436937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.